A study on steroid hormone metabolites of patients with type 2 diabetes mellitus

Single-center observation of metabolomics and steroid hormone metabolites in patients with type 2 diabetes based on liquid chromatography-mass spectrometry

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300073648

Enrollment

Unknown

Registered

2023-07-18

Start date

2023-08-01

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes mellitus

Interventions

Type II diabetes patients group:none

Healthy control group:none

Eligibility

Sex/Gender

All

Age

30 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) The patient meets the diagnostic criteria for T2DM; (2) Men aged 30-70 and postmenopausal women aged 55-70 have complete information about the patient; (3) Patients who have not used any sex hormone drugs or any hypoglycemic drugs in the past 3 months; (4) Informed consent and voluntary participation.

Exclusion criteria

Exclusion criteria: (1) Patients with major diseases such as liver and kidney dysfunction and malignant tumors, as well as those with diseases that affect sexual hormones in the body; (2) Pregnant women.

Design outcomes

Primary

Measure	Time frame
steroid hormone;	—

Secondary

Measure	Time frame
body mass index;Glucose;	—

Countries

China

Contacts

Public ContactYang Na

Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School

shillingyang@163.com+86 181 1516 1056

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026